ZIPRASIDONE MESYLATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ziprasidone Mesylate, and when can generic versions of Ziprasidone Mesylate launch?
Ziprasidone Mesylate is a drug marketed by Gland Pharma Ltd and MSN and is included in two NDAs.
The generic ingredient in ZIPRASIDONE MESYLATE is ziprasidone mesylate. There are twenty-three drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the ziprasidone mesylate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ziprasidone Mesylate
A generic version of ZIPRASIDONE MESYLATE was approved as ziprasidone mesylate by GLAND PHARMA LTD on December 26th, 2019.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ZIPRASIDONE MESYLATE?
- What are the global sales for ZIPRASIDONE MESYLATE?
- What is Average Wholesale Price for ZIPRASIDONE MESYLATE?
Summary for ZIPRASIDONE MESYLATE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 5 |
| Raw Ingredient (Bulk) Api Vendors: | 56 |
| Clinical Trials: | 1 |
| Patent Applications: | 181 |
| DailyMed Link: | ZIPRASIDONE MESYLATE at DailyMed |
Recent Clinical Trials for ZIPRASIDONE MESYLATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Yang Fude | Phase 4 |
| Pfizer | Phase 4 |
Pharmacology for ZIPRASIDONE MESYLATE
| Drug Class | Atypical Antipsychotic |
Anatomical Therapeutic Chemical (ATC) Classes for ZIPRASIDONE MESYLATE
US Patents and Regulatory Information for ZIPRASIDONE MESYLATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gland Pharma Ltd | ZIPRASIDONE MESYLATE | ziprasidone mesylate | POWDER;INTRAMUSCULAR | 211908-001 | Dec 26, 2019 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Msn | ZIPRASIDONE MESYLATE | ziprasidone mesylate | POWDER;INTRAMUSCULAR | 216091-001 | Sep 15, 2022 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
